The persistent myth: "If I feel good, I'm safe." Cancer contradicts this. Many relevant precursors cause symptoms for a long time – and it is here that early detection gains precious years. Surprisingly, in a large US analysis, over 77,000 women utilized a digital risk tool prior to mammography; more than one in ten had a significantly elevated lifetime risk for breast cancer – despite often feeling quite well in their daily lives ^[1].

Cancer prevention targets three levels: primary prevention (reducing risk), secondary prevention (early detection), and tertiary prevention (preventing recurrences). Central for women are screening for cervical cancercancer of the cervix, almost always caused by high-risk HPV, screening and risk scoring for breast cancerthe most common cancer in women, and recognizing familial BRCA mutationshereditary genetic changes that significantly increase the risk of breast and ovarian cancer. It is important to differentiate between cytologycell smear from the cervix, e.g., Pap test, HPV co-testingcombination of Pap and HPV test, and colposcopymagnified inspection of the cervix for clarification. For high performers, prevention is not an "appointment," but a system of regular checks, personalized risk management, and a lifestyle that minimizes inflammation, hormonal imbalances, and DNA damage.

Early detection saves lives because it intercepts precursors before metastases develop. In Germany, organized cervical screening with cytology and HPV-supported clarification shows that relevant precursors (CIN3+) are detected in double-digit percentages even in cases of moderate cellular changes – a strong signal for the benefits of early diagnostics ^[2]. Smoking multiplies the cervical cancer risk; current data demonstrates a causal relationship, with significantly increased odds for current smokers – a direct lever for prevention ^[3]. Sun protection is also women's health: In a large long-term cohort, high UV exposure plus tanning bed use particularly increased the risk of basal cell carcinoma – an example of how daily habits can undermine cancer prevention ^[4][5]. Meanwhile, a favorable lifestyle significantly reduces overall cancer risk, even in those with pre-existing frailty – health pathways can thus be modulated ^[6]. Additionally, vitamin D3 has shown a reduction in overall cancer mortality and evidence of prevention for several types of tumors in reviews – deficiencies should be actively identified and corrected ^[7].

Digital risk stratification shifts breast cancer prevention toward precision. In Connecticut, over two years, more than 77,000 risk assessments were completed before mammography; 10.4% of women had a lifetime risk greater than 20% according to Tyrer-Cuzick. A quarter met criteria for genetic testing, and pathogenic mutations were found in 9% of those tested. Multilingualism and broad participation reduced access barriers – a practical approach to fairer prevention ^[1]. For cervical cancer, organized screening with a fixed clarification algorithm demonstrates a high detection rate for CIN3+ in relevant finding groups. The fact that there remains a non-trivial precursory risk even in the presence of persistent HPV infection with normal cytology explains why structured co-testing and early colposcopy are sensible. A differentiation according to high-risk HPV types could further increase precision ^[2]. Hereditary risks remain an underestimated game-changer: For carriers of BRCA1/2, the lifetime risk for breast cancer is about 70%, and for ovarian cancer is approximately 44% (BRCA1) or 17% (BRCA2). Guidelines recommend tiered strategies from intensified screening to risk-reducing surgeries; meanwhile, genetic testing is underutilized globally – hampered by barriers such as costs, access to counseling, and knowledge gaps ^[8][9][10].

- Consistently utilize Pap and HPV co-tests: In Germany, cytology annually from age 20; co-test every three years from age 35 – do not delay clarifications for abnormalities ^[2].
- Clarify personal risk profile: Prior to mammography, conduct a standardized digital risk assessment or discuss risk factors (age, density, family history) with your gynecologist; this may result in more frequent imaging or chemoprevention ^[1].
- Proactively address genetics: For a family history of breast/ovarian cancer, consider genetic counseling and potentially BRCA testing; results guide surveillance, medical prevention, and possibly risk-reducing interventions ^[8][9].
- Lifestyle as a multiplier: Do not smoke or quit smoking immediately (cervical and breast cancer risk decreases) ^[3]; check vitamin D status (25-OH-D) and correct deficiencies, as supplements can reduce cancer mortality ^[7]; eat a balanced diet, exercise regularly, and aim for a healthy weight – this combination lowers overall cancer risk even in frailty ^[6].
- UV management: Use daily broad-spectrum sun protection, seek shade, and strictly avoid tanning beds; particularly with high historical UV exposure, this protects against non-melanocytic skin cancer ^[4][5].

The future of cancer prevention is personalized, digitally supported, and barrier-free: Risk tools, HPV typing, and scaled genetics can make screening more precise and equitable. Next steps in research will clarify how combined lifestyle interventions with vitamin D optimization, smoking cessation, and data-driven screening can further reduce cancer mortality in women – individualized dosing, maximally effective.